Hypersensitivity reactions (HSRs) to platinum-based chemotherapies are increasing as cancer rates are rising. Desensitization protocols allow patients to receive first-line therapy despite HSRs, but are often performed in the inpatient setting for close monitoring by trained personnel and to mitigate risk. We aimed to evaluate a safe and effective strategy for performing desensitizations in the outpatient setting, with a focus on decreasing delays in medication administration, patient inconvenience, and overall treatment time.
http://ift.tt/2zbfw6e
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου